Mycophenolate Mofetil for the Treatment of Systemic Sclerosis

E-ISSN： 1875-628x|5|2|134-136

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.5, Iss.2, 2008-03, pp. : 134-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Use of Mycophenolate Mofetil for the Treatment of Systemic Sclerosis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 1, 2008-03 ,pp. : 11-14

Bentham Science Publishers

Access to resources Recommend Favorite

Mycophenolate mofetil/tacrolimus: Systemic sarcoidosis in a child: case report

Reactions Weekly, Vol. 1, Iss. 1132, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Defining the Role of Mycophenolate Mofetil in the Treatment of Proliferative Lupus Nephritis

By Lenz Oliver Fornoni Alessia Contreras Gabriel

Drugs, Vol. 65, Iss. 17, 2005-01 ,pp. : 2429-2436

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Mycophenolate Mofetil

By Bullingham R.E.S. Nicholls A.J. Kamm B.R.

Clinical Pharmacokinetics, Vol. 34, Iss. 6, 1998-06 ,pp. : 429-455

Adis International

Access to resources Recommend Favorite

The safety of mycophenolate mofetil in pregnancy

By Pisoni Cecilia N D'Cruz David P

Expert Opinion on Drug Safety, Vol. 7, Iss. 3, 2008-05 ,pp. : 219-222

Informa Healthcare

Access to resources Recommend Favorite